Skin Cancer/Sunscreen - The Dilemma with Dr. Edward Gorham, PhD
Activity Description Despite increases in sunscreen use and sun avoidance, melanoma is the most rapidly increasing skin malignancy. Could there be other factors that contribute to the risk of melanoma, and what role does the sun play? In this talk, Edward Gorham, PhD, discusses the dilemma of skin cancer and sunscreen use, and talks in depth about the difference between UVA and UVB exposure, the body’s physiological response to each type of irradiance, and how sun exposure and sunscreens affect the risk of skin cancers and vitamin D production. Objectives Upon completion of this activity, participants should be able to:
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program. NURSES: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 1.0 hour of credit and list "CME Category 1" as the provider number).
Release Date: May 18, 2016 Expiration Date: May 17, 2017 Course Director Cedric Garland, DrPH, FACE Professor of Epidemiology University of California, San Diego San Diego, California Faculty Edward Gorham, PhD Associate Professor Department of Family Medicine and Public Health University of California, San Diego San Diego, California Balance and Objectivity of Content It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity. Participants will be asked to evaluate whether the speaker's outside interests reflect a possible bias in the planning or presentation of the activity. This information is used to plan future activities. Disclosures Drs. Garland and Gorham have no disclosures relevant to the topic presented in this activity. The CME staff, meeting planners, editorial staff, planning committee, peer reviewer and CME committee reviewers do not have any relevant financial relationships to disclose.
Off-label Disclosure: This educational activity may contain discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the prescribing information for each product.
The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California, San Diego and GrassrootsHealth.
9500 Gilman Drive, MC 0947 La Jolla, California 92093-0947 858-534-3940 - 888-229-6263 email@example.com - cme.ucsd.edu